Skip to main content
Fig. 11 | BMC Medical Genomics

Fig. 11

From: Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma

Fig. 11

Biological function and pathway enrichment analysis of DEGs based on the mcrmRNA prognostic risk model (A) GO Enrichment Analysis. BP, biological process; CC, cellular component; and MF, molecular function. B KEGG Pathway Analysis. C GSEA Enrichment Analysis showing the activation status of biological pathways in the high- and low-risk groups

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us